DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Konstantinopoulos PA, Waggoner S, Vidal GA. et al.
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma.
JAMA Oncol 2019;
DOI: 10.1001/jamaoncol.2019.1048.
We do not assume any responsibility for the contents of the web pages of other providers.